Quantcast

Latest Risperidone Stories

2013-11-05 23:01:26

Global healthcare giant Johnson & Johnson and its Janssen subsidiary will pay more than $2.2 billion to settle allegations related to the off-label marketing of the anti-psychotic drug Risperdal, plus two other drugs. Parker Waichman LLP commends several whistleblowers who will be awarded millions of dollars in compensation for their efforts to expose alleged fraud. New York, New York (PRWEB) November 05, 2013 Parker Waichman LLP, a national law firm dedicated to protecting the rights...

2013-11-04 23:20:22

Sheller, P.C. Law Firm Represents “First to File” Pharmaceutical Industry Whistleblower for Record-Breaking $2+ Billion Settlement bringing Firm’s Recoveries to over $6 Billion Philadelphia, PA (PRWEB) November 04, 2013 Healthcare giant Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals (J&J), will pay the federal government more than $2 billion in civil settlement and criminal fines to settle charges that Janssen Pharmaceuticals illegally marketed the blockbuster...

2013-11-04 23:01:50

The Firm is investigating an alleged association between Risperdal and gynecomastia, or male breast growth. New York, NY (PRWEB) November 04, 2013 As Risperdal lawsuits (http://www.therisperdallawsuit.com) involving allegations that use of the antipsychotic drug caused gynecomastia, or male breast growth, continue to mount in courts throughout the country, Bernstein Liebhard LLP notes that Johnson & Johnson has agreed to pay $2.2 billion to settle a government probe into the marketing...

2013-11-04 23:00:33

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) November 04, 2013 The medication safety advocates at DrugNews.net are announcing the launch of a new resource site for patients taking the antipsychotic drug Risperdal. Information will be available on studies into the drug’s side effects, the issuance of safety alerts, as well as legal news for any injury...

2013-10-24 23:02:30

Bernstein Liebhard LLP is actively investigating potential Risperdal gynecomastia lawsuit claims on behalf of men and boys who may have developed male breast growth after taking the antipsychotic drug. New York, NY (PRWEB) October 24, 2013 A new Risperdal lawsuit (http://www.therisperdallawsuit.com/) alleging gynecomastia, or male breast growth, has been filed in a consolidated litigation underway in Pennsylvania state court, Bernstein Liebhard LLP reports. According to recent court...

2013-10-22 23:34:34

Court Documents Indicate that More than 200 Risperdal Lawsuits Are Now Pending in a Mass Tort Litigation in Pennsylvania’s Philadelphia Court of Common Pleas Columbus, OH (PRWEB) October 22, 2013 Risperdal lawsuits are now being evaluated by Wright & Schulte LLC, an experienced personal injury law firm, on behalf of young men and boys who developed gynecomastia (male breast growth) allegedly due to Risperdal. According to court documents, at least 230 Risperdal lawsuits are now...

2013-10-21 23:01:46

The Firm is investigating the alleged association between Risperdal and male breast growth, also known as gynecomastia. New York, New York (PRWEB) October 21, 2013 The nationwide law firm of Bernstein Liebhard LLP (http://www.consumerinjurylawyers.com) is investigating Risperdal lawsuits on behalf of young men and boys who developed a condition called gynecomastia, or male breast growth, allegedly due to their use of Risperdal. “We are interested in hearing from anyone who developed...

2013-08-22 10:29:47

Prescribing of "atypical" antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows. Young people using medications like risperidone, quetiapine, aripiprazol and olanzapine led to a threefold increased risk of developing type 2 diabetes within the first year of taking the drug, according to the study published Aug. 21 in the journal JAMA...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.